EGFR and inflammatory breast carcinoma: Zhang et al. [16] reported that the epidermal growth factor receptor (EGFR) pathway was involved in tumor growth and metastasis of IBC through EMT and that EGFR expression was an independent and poor prognostic factor in IBC [18,19].